Transfusion medicine service policies for recombinant factor VIIa administration.

The increasing success reported in the use of rFVIIa to control severe bleeding in surgery and trauma in hemophilia and non-hemophilia patients has made it necessary to formulate protocols and guidelines which may be followed in managing such patients. This is an excellent paper by transfusion medicine service at Washington University School of Medicine which […]